GlassScriptPhysician profile
Bimal A Patel
NPI 1174899116
$11,461.19
in general payments reported to CMS, 2019-2025
41 companies · $709 in 2025
The $709 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,689 · 2020: $734 · 2021: $547 · 2022: $800 · 2023: $1,200 · 2024: $1,783 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,691.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $2,306.74 | 2019 | |
| Nevro Corp. | $2,182.33 | 2019-2024 | Senza |
| Abbott Laboratories | $1,016.49 | 2019-2025 | Eterna, Proclaim, Freestyle Libre 3 |
| Saluda Medical Americas, INC. | $904.08 | 2022-2024 | Evoke, Evoke Scs |
| Vertos Medical, INC. | $837.85 | 2019-2023 | Mild Device Kit |
| Boston Scientific Corporation | $644.30 | 2021-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Biotronik Nro, INC. | $594.15 | 2023-2025 | Prospera, Biotronik |
| Collegium Pharmaceutical, INC. | $473.15 | 2019-2023 | Belbuca |
| Scilex Pharmaceuticals INC. | $369.98 | 2019-2024 | Ztlido |
| Medtronic, INC. | $266.36 | 2021-2025 | Graftonand Grafton Plusdemineralized Bone Matrix (Dbm) |
| Globus Medical, INC. | $208.70 | 2025 | Senza |
| Averitas Pharma INC. | $163.96 | 2023-2025 | Qutenza |
| Abbvie INC. | $149.72 | 2021-2024 | |
| Si-Bone, INC. | $146.85 | 2019-2023 | |
| Spr Therapeutics, INC | $136.07 | 2021-2025 | Sprint Pns System |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bimal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.